Atorvastatin tert-Butyl Ester is a fluorinated pyrrole-lactone derivative featuring a sterically hindered tert-butyl ester group appended to the hydroxyl-bearing carbon of the Atorvastatin scaffold. The esterification introduces a branched, hydrophobic tert-butyl moiety, which modulates solubility and metabolic stability while retaining the core pharmacophoric elements of the parent compound. Structurally, it retains the 2-(4-fluorophenyl)-3-methyl-4-phenyl-1H-pyrrole-1,3(2H)-dione framework, with the ester linkage positioned at the ฮฒ-hydroxy acid functionality. This compound arises as a synthetic byproduct during Atorvastatin esterification steps, serving as a critical impurity reference standard for HPLC-based purity analysis in drug substance characterization.
On Request| Std | Catalog # | Quantity | Price |
|---|---|---|---|
| USP | 1A00830 โ | 25 mg | USD 936.00 |
CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)OC(C)(C)C)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4
InChI=1S/C37H43FN2O5/c1-24(2)34-33(36(44)39-28-14-10-7-11-15-28)32(25-12-8-6-9-13-25)35(26-16-18-27(38)19-17-26)40(34)21-20-29(41)22-30(42)23-31(43)45-37(3,4)5/h6-19,24,29-30,41-42H,20-23H2,1-5H3,(H,39,44)/t29-,30-/m1/s1
GCPKKGVOCBYRML-LOYHVIPDSA-N